Indrayani Biotech News

Indrayani Biotech postpones rights issue

Indrayani Biotech Ltd has postponed its partly paid-up rights issue schedule until further notice. The issue was initially set to open on May 27, 2026.

Indrayani Biotech CS resigns

Indrayani Biotech Limited's Company Secretary and Compliance Officer Ramya Ravi resigned effective June 3, 2026, due to professional reasons.

Indrayani Biotech delays FY26 audited results

Indrayani Biotech Limited will hold its board meeting for FY26 audited results at a later date due to delays in consolidation and audits. The trading window remains closed until 48 hours after results declaration.

Indrayani Biotech director resigns citing governance lapses

Whole-Time Director S. Indirakumar resigned citing statutory violations and unpaid dues. The company faces significant tax and compliance issues.

Indrayani Biotech revises rights issue dates

Indrayani Biotech Limited revised its rights issue schedule, moving the opening date to June 25, 2026, and closing to July 24, 2026. The on-market renunciation date is now July 20, 2026.